Evidence map›Paper›PMID 28135057›Full record

ArticleACS chemical biology2017

The Small Molecule 2-Azido-2-deoxy-glucose Is a Metabolic Chemical Reporter of O-GlcNAc Modifications in Mammalian Cells, Revealing an Unexpected Promiscuity of O-GlcNAc Transferase.

Balyn W Zaro, Anna R Batt, Kelly N Chuh, Marisol X Navarro, Matthew R Pratt

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Chemical science · 2021
    Article
  8. Advances in chemical probing of proteinChemical Society reviews · 2021
    Review
  9. Chemical reporters to study mammalian O-glycosylation.Biochemical Society transactions · 2021
    Review
  10. Article
  11. Review
  12. The Metabolic Chemical Reporter AcFrontiers in chemistry · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Balyn W ZaroDepartment of Chemistry and ‡Department of Molecular and Computational Biology, University of Southern California , Los Angeles, California 90089-0744, United States.
Anna R BattDepartment of Chemistry and ‡Department of Molecular and Computational Biology, University of Southern California , Los Angeles, California 90089-0744, United States.
Kelly N ChuhDepartment of Chemistry and ‡Department of Molecular and Computational Biology, University of Southern California , Los Angeles, California 90089-0744, United States.
Marisol X NavarroDepartment of Chemistry and ‡Department of Molecular and Computational Biology, University of Southern California , Los Angeles, California 90089-0744, United States.
Matthew R PrattDepartment of Chemistry and ‡Department of Molecular and Computational Biology, University of Southern California , Los Angeles, California 90089-0744, United States.ORCID 0000-0003-3205-5615
University of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
NCI NIH HHS P30 CA014089
6 · The paper itself

Abstract

Glycans can be directly labeled using unnatural monosaccharide analogs, termed metabolic chemical reporters (MCRs). These compounds enable the secondary visualization and identification of glycoproteins by taking advantage of bioorthogonal reactions. Most widely used MCRs have azides or alkynes at the 2-N-acetyl position but are not selective for one class of glycoprotein over others. To address this limitation, we are exploring additional MCRs that have bioorthogonal functionality at other positions. Here, we report the characterization of 2-azido-2-deoxy-glucose (2AzGlc). We find that 2AzGlc selectively labels intracellular O-GlcNAc modifications, which further supports a somewhat unexpected, structural flexibility in this pathway. In contrast to the endogenous modification N-acetyl-glucosamine (GlcNAc), we find that 2AzGlc is not dynamically removed from protein substrates and that treatment with higher concentrations of per-acetylated 2AzGlc is toxic to cells. Finally, we demonstrate that this toxicity is an inherent property of the small-molecule, as removal of the 6-acetyl-group renders the corresponding reporter nontoxic but still results in protein labeling.

Indexed as

AcetylglucosamineAnimalsChromatography, LiquidDeoxyglucoseMiceN-AcetylglucosaminyltransferasesNIH 3T3 CellsTandem Mass SpectrometryAcetylglucosamineDeoxyglucoseN-AcetylglucosaminyltransferasesO-GlcNAc transferase

Identifiers

PMID28135057
PMCPMC6223259
OpenAlexW2558463933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.